ReviewInternational journal of molecular sciences2026
The Hodgkin Lymphoma Microenvironment: Insights from Spatial Transcriptomics.
Review in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Classical Hodgkin lymphoma (cHL) is a paradigmatic example of a malignancy in which the tumor microenvironment (TME) plays a dominant role in disease biology. Malignant Hodgkin and Reed-Sternberg (HRS) cells typically constitute only a small minority of the tumor mass (approximately 1-5%). HRS cells are embedded within a complex, highly structured immune and stromal milieu that drives survival, immune evasion, and therapy response. Over the past decade, transcriptomic approaches, particularly single-cell RNA sequencing, have reshaped our understanding of cellular heterogeneity within cHL. However, these approaches lack spatial context, a limitation that is especially relevant in cHL, where cell-cell interactions and physical proximity are central to immune evasion and tumor support. Recent advances in spatial transcriptomics now enable genome-scale, spatially resolved interrogation of gene expression in situ. In this review, we summarize spatially resolved studies of the cHL microenvironment, discuss what they reveal about HRS-centered cellular niches and immune evasion, and highlight how these findings may inform risk stratification, biomarker discovery and microenvironment-directed therapies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.